Skip to content
Bolzano Startup

Social Media Content Creators Driving Unofficial Trade for Unapproved Slimming Medication

A shadow economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering products of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has removed violative material and banned associated hashtags and query recommendations. The company said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with images of weight loss, glowing reviews and step-by-step instructions for preparing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to potentially serious health risks”.

The writer

Corey Cummings

A tech enthusiast and lifestyle blogger passionate about sharing practical advice and inspiring stories.

Bolzano Startup

Type to search articles.